Keywords: zeneca, tomudex, launched, first, market, several, months

Zeneca's Tomudex Launched In First Market

Article | 11 March 1996

Several months later than expected, Zeneca has launched Tomudex (raltitrexed), the first single-agent cytotoxic for the first-line palliative treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in